Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressants and Bone Mineral Density in Depression
NCT02179268Phase 3Completed
- Sponsor
- Guizhou Medical University
- Start
- Mar 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sertraline, citalopram, venlafaxine, reboxetine in major depressive disorder (MDD), sponsored by Guizhou Medical University. Started Mar 2012; status: completed.
02
Drugs
sertralinecitalopramvenlafaxinereboxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02179268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02179268.